TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis

Overview

Journal Front Pharmacol

Date 2022 Apr 11

PMID 35401211

Authors

Xiao-Yong Yu

Qian Sun

Ya-Mei Zhang

Liang Zou

Ying-Yong Zhao

Affiliations

Soon will be listed here.

Abstract

Chronic kidney disease (CKD) was a major public health problem worldwide. Renal fibrosis, especially tubulointerstitial fibrosis, is final manifestation of CKD. Many studies have demonstrated that TGF-β/Smad signaling pathway plays a crucial role in renal fibrosis. Therefore, targeted inhibition of TGF-β/Smad signaling pathway can be used as a potential therapeutic measure for tubulointerstitial fibrosis. At present, a variety of targeting TGF-β1 and its downstream Smad proteins have attracted attention. Natural products used as potential therapeutic strategies for tubulointerstitial fibrosis have the characteristics of acting on multiple targets by multiple components and few side effects. With the continuous research and technique development, more and more molecular mechanisms of natural products have been revealed, and there are many natural products that inhibited tubulointerstitial fibrosis TGF-β/Smad signaling pathway. This review summarized the role of TGF-β/Smad signaling pathway in tubulointerstitial fibrosis and natural products against tubulointerstitial fibrosis by targeting TGF-β/Smad signaling pathway. Additionally, many challenges and opportunities are presented for inhibiting renal fibrosis in the future.

Citing Articles

Dapagliflozin inhibits ferroptosis and ameliorates renal fibrosis in diabetic C57BL/6J mice.

Zhang Z, Li L, Dai Y, Lian Y, Song H, Dai X Sci Rep. 2025; 15(1):7117.

PMID: 40016517 PMC: 11868513. DOI: 10.1038/s41598-025-91278-4.

Astragalus Mongholicus Polysaccharides Alleviate Kidney Injury in Rats with Type 2 Diabetes Through Modulation of Oxidation, Inflammation, and Gut Microbiota.

Xu G, Yuan H, Liu J, Wang X, Ma L, Wang Y Int J Mol Sci. 2025; 26(4).

PMID: 40003935 PMC: 11855448. DOI: 10.3390/ijms26041470.

Interrelation of Natural Polyphenol and Fibrosis in Diabetic Nephropathy.

Ma Y, Wang J, Fan J, Jia H, Li J Molecules. 2025; 30(1).

PMID: 39795078 PMC: 11722366. DOI: 10.3390/molecules30010020.

The Complex Role of Matrix Metalloproteinase-2 (MMP-2) in Health and Disease.

Wolosowicz M, Prokopiuk S, Kaminski T Int J Mol Sci. 2025; 25(24.

PMID: 39769454 PMC: 11728377. DOI: 10.3390/ijms252413691.

Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation.

Li G, Xian S, Cheng X, Hou Y, Jia W, Ma Y Front Pharmacol. 2024; 15:1499012.

PMID: 39687299 PMC: 11646733. DOI: 10.3389/fphar.2024.1499012.

References

Shao G, Zhu S, Yang B . Applications of Herbal Medicine to Treat Autosomal Dominant Polycystic Kidney Disease. Front Pharmacol. 2021; 12:629848. PMC: 8111540. DOI: 10.3389/fphar.2021.629848. View

Wang M, Chen D, Chen L, Cao G, Zhao H, Liu D . Novel inhibitors of the cellular renin-angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β-catenin pathway against renal fibrosis. Br J Pharmacol. 2018; 175(13):2689-2708. PMC: 6003649. DOI: 10.1111/bph.14333. View

Sun H, Ke C, Zhang L, Tian C, Zhang Z, Wu S . Long Non-Coding RNA (LncRNA)-ATB Promotes Inflammation, Cell Apoptosis and Senescence in Transforming Growth Factor-β1 (TGF-β1) Induced Human Kidney 2 (HK-2) Cells via TGFβ/SMAD2/3 Signaling Pathway. Med Sci Monit. 2020; 26:e922029. PMC: 7265746. DOI: 10.12659/MSM.922029. View

Wang L, Cao A, Chi Y, Ju Z, Yin P, Zhang X . You-gui Pill ameliorates renal tubulointerstitial fibrosis via inhibition of TGF-β/Smad signaling pathway. J Ethnopharmacol. 2015; 169:229-38. DOI: 10.1016/j.jep.2015.04.037. View

Lee S, Kim S, Choi M . Therapeutic targets for treating fibrotic kidney diseases. Transl Res. 2014; 165(4):512-30. PMC: 4326607. DOI: 10.1016/j.trsl.2014.07.010. View

Chen L, Chen D, Liu J, Zhang J, Vaziri N, Zhuang S . Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis. Exp Mol Med. 2019; 51(3):1-18. PMC: 6437207. DOI: 10.1038/s12276-019-0234-2. View

Chen W, Ten Dijke P . Immunoregulation by members of the TGFβ superfamily. Nat Rev Immunol. 2016; 16(12):723-740. DOI: 10.1038/nri.2016.112. View

Chen H, Cao G, Chen D, Wang M, Vaziri N, Zhang Z . Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression. Redox Biol. 2016; 10:168-178. PMC: 5066525. DOI: 10.1016/j.redox.2016.09.014. View

Ma G, Chen F, Liu Y, Zheng L, Jiang X, Tian H . Nur77 ameliorates age-related renal tubulointerstitial fibrosis by suppressing the TGF-β/Smads signaling pathway. FASEB J. 2021; 36(2):e22124. DOI: 10.1096/fj.202101332R. View

10.

Sureshbabu A, Muhsin S, Choi M . TGF-β signaling in the kidney: profibrotic and protective effects. Am J Physiol Renal Physiol. 2016; 310(7):F596-F606. PMC: 4824143. DOI: 10.1152/ajprenal.00365.2015. View

11.

Nakerakanti S, Trojanowska M . The Role of TGF-β Receptors in Fibrosis. Open Rheumatol J. 2012; 6:156-62. PMC: 3396054. DOI: 10.2174/1874312901206010156. View

12.

Zhang Y, Tang P, Chiu-Tsun Tang P, Xiao J, Huang X, Yu C . LRNA9884, a Novel Smad3-Dependent Long Noncoding RNA, Promotes Diabetic Kidney Injury in / Mice via Enhancing MCP-1-Dependent Renal Inflammation. Diabetes. 2019; 68(7):1485-1498. DOI: 10.2337/db18-1075. View

13.

Zhao Y, Feng Y, Du X, Xi Z, Cheng X, Wei F . Diuretic activity of the ethanol and aqueous extracts of the surface layer of Poria cocos in rat. J Ethnopharmacol. 2012; 144(3):775-8. DOI: 10.1016/j.jep.2012.09.033. View

14.

Liu Z, Huang X, Chen H, Fung E, Liu J, Lan H . Deletion of Angiotensin-Converting Enzyme-2 Promotes Hypertensive Nephropathy by Targeting Smad7 for Ubiquitin Degradation. Hypertension. 2017; 70(4):822-830. DOI: 10.1161/HYPERTENSIONAHA.117.09600. View

15.

Feng Y, Cao G, Chen D, Vaziri N, Chen L, Zhang J . Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease. Cell Mol Life Sci. 2019; 76(24):4961-4978. PMC: 11105293. DOI: 10.1007/s00018-019-03155-9. View

16.

Li J, Yang Sun Y, Chen W, Fan J, Li S, Qu X . Smad4 promotes diabetic nephropathy by modulating glycolysis and OXPHOS. EMBO Rep. 2020; 21(2):e48781. PMC: 7001498. DOI: 10.15252/embr.201948781. View

17.

Newman D, Cragg G . Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. J Nat Prod. 2020; 83(3):770-803. DOI: 10.1021/acs.jnatprod.9b01285. View

18.

Wang M, Hu H, Chen Y, Chen L, Wu X, Zhao Y . Novel poricoic acids attenuate renal fibrosis through regulating redox signalling and aryl hydrocarbon receptor activation. Phytomedicine. 2020; 79:153323. DOI: 10.1016/j.phymed.2020.153323. View

19.

Meng X, Nikolic-Paterson D, Lan H . TGF-β: the master regulator of fibrosis. Nat Rev Nephrol. 2016; 12(6):325-38. DOI: 10.1038/nrneph.2016.48. View

20.

Wang Y, Wang Y, Yang M, Ma X . Implication of cellular senescence in the progression of chronic kidney disease and the treatment potencies. Biomed Pharmacother. 2021; 135:111191. DOI: 10.1016/j.biopha.2020.111191. View